These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1851051)

  • 1. Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. A Nuclear Magnetic Resonance study.
    Barzilai A; Horowitz A; Geier A; Degani H
    Cancer; 1991 Jun; 67(11):2919-25. PubMed ID: 1851051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton NMR of human breast tumors: correlation with clinical prognostic parameters.
    Chu DZ; Yamanashi WS; Frazer J; Hazlewood CF; Gallager HS; Boddie AW; Martin RG
    J Surg Oncol; 1987 Sep; 36(1):1-4. PubMed ID: 3041112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast tumors: evaluation with P-31 MR spectroscopy.
    Degani H; Horowitz A; Itzchak Y
    Radiology; 1986 Oct; 161(1):53-5. PubMed ID: 3020609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphometric correlates of the steroid receptor content in invasive ductal breast cancers].
    Mattfeldt T; Neurohr W; Müller A; Klinga K
    Verh Dtsch Ges Pathol; 1985; 69():350-5. PubMed ID: 3006385
    [No Abstract]   [Full Text] [Related]  

  • 5. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
    Remmele W; Schicketanz KH
    Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
    [No Abstract]   [Full Text] [Related]  

  • 7. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.
    Sijens PE; Wijrdeman HK; Moerland MA; Bakker CJ; Vermeulen JW; Luyten PR
    Radiology; 1988 Dec; 169(3):615-20. PubMed ID: 2847230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
    El Sharkawy SL; Farrag AR
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
    Ronay G; Sponsel N; Tulusan AH
    Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
    Kasch R; Meissner J; Haack D; Neumann S
    Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic response of breast carcinoma monitored by 31P MRS in situ.
    Ng TC; Grundfest S; Vijayakumar S; Baldwin NJ; Majors AW; Karalis I; Meaney TF; Shin KH; Thomas FJ; Tubbs R
    Magn Reson Med; 1989 Apr; 10(1):125-34. PubMed ID: 2547134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer.
    Nomura Y; Tashiro H; Shinozuka K
    Cancer; 1985 Feb; 55(3):546-51. PubMed ID: 3965108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay].
    Mauriac L; Wafflart J; Trojani M; Durand M
    Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
    Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
    Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
    Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease.
    Jeon MJ; Lee Y; Ahn S; Lee C; Kim OH; Oh BC; Yu U; Kim H
    Acta Radiol; 2015 Sep; 56(9):1051-60. PubMed ID: 25270373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracystic papillary carcinoma of the breast: report of three cases].
    El mazghi A; Bouhafa T; Loukili K; El kacemi H; Lalya I; Kebdani T; Hassouni K
    Pan Afr Med J; 2014; 18():207. PubMed ID: 25419333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.